AstraZeneca discovers, develops, and commercializes prescription medicines with particular strength in oncology, respiratory diseases, and cardiovascular and metabolic conditions. Its portfolio features several leading therapies and a pipeline centered on biologics and precision approaches. The company provides these medicines to patients and health systems around the world.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 14,457 | — | 2,450 | — |
| Q3 2025 | 15,191 | — | 2,533 | — |
| Q4 2025 | 15,503 | — | 2,326 | — |
| Q1 2026 | 15,288 | — | 3,080 | — |
| Q2 2026 | 15,384 | 6.4% | 2,507 | 2.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Thermo Fisher Scientific Inc. (TMO), Wells Fargo & Company (WFC), Mitsubishi UFJ Financial Group, Inc. (MUFG), GE Vernova Inc. (GEV), Toyota Motor Corporation (TM), Arista Networks, Inc. (ANET)